Ashley M Cimino-Mathews

Associate Professor

20032019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Ashley M Cimino-Mathews is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Breast Medicine & Life Sciences
Estrogen Receptors Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Large-Core Needle Biopsy Medicine & Life Sciences
Immunohistochemistry Medicine & Life Sciences
Tumor-Infiltrating Lymphocytes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2019

Fibroepithelial Neoplasms
Large-Core Needle Biopsy
Breast
Fibroadenoma
Carcinoma

A phase i study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1-3 inhibitor, cediranib, in recurrent women's cancers with biomarker analyses

Zimmer, A. S., Nichols, E., Cimino-Mathews, A. M., Peer, C., Cao, L., Lee, M. J., Kohn, E. C., Annunziata, C. M., Lipkowitz, S., Trepel, J. B., Sharma, R., Mikkilineni, L., Gatti-Mays, M., Figg, W. D., Houston, N. D. & Lee, J. M., Jul 25 2019, In : Journal for immunotherapy of cancer. 7, 1, 197.

Research output: Contribution to journalArticle

Open Access
Tumor Biomarkers
Complement Inactivating Agents
Drug Combinations
Pharmacokinetics
Triple Negative Breast Neoplasms

High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer

Gorbounov, M., Carleton, N. M., Asch-Kendrick, R. J., Xian, L., Rooper, L., Chia, L., Cimino-Mathews, A., Cope, L., Meeker, A., Stearns, V., Veltri, R. W., Bae, Y. K. & Resar, L. M. S., Jan 1 2019, (Accepted/In press) In : Breast Cancer Research and Treatment.

Research output: Contribution to journalArticle

High Mobility Group Proteins
Estrogen Receptors
Breast Neoplasms
Gene Expression
Neoplasms

TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast Cancer

Connolly, R., Leal, J. P., Solnes, L., Huang, C. Y., Carpenter, A., Gaffney, K., Abramson, V., Carey, L. A., Liu, M. C., Rimawi, M., Specht, J., Storniolo, A. M., Valero, V., Vaklavas, C., Krop, I. E., Winer, E. P., Camp, M., Miller, R. S., Wolff, A. C., Cimino-Mathews, A. M. & 3 others, Park, B. H., Wahl, R. L. & Stearns, V., Mar 20 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 9, p. 714-722 9 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Fluorodeoxyglucose F18
Estrogen Receptors
Area Under Curve
ROC Curve

A primary breast cancer with distinct foci of estrogen receptor-alpha positive and negative cells derived from the same clonal origin as revealed by whole exome sequencing

Kyker-Snowman, K., Erlanger Avigdor, B., Nasim, M., Cimino-Mathews, A. M., Wheelan, S., Argani, P. & Park, B. H., Mar 15 2018, (Accepted/In press) In : Breast Cancer Research and Treatment. p. 1-6 6 p.

Research output: Contribution to journalArticle

Exome
Estrogen Receptor alpha
Estrogen Receptors
Breast Neoplasms
Neoplasms